• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乳酸-羟基乙酸共聚物纳米球中紫杉醇的负载量影响了药物的体外细胞蓄积和抗增殖活性。

Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.

作者信息

Vicari Luisa, Musumeci Teresa, Giannone Ignazio, Adamo Luana, Conticello Concetta, De Maria Ruggero, Pignatello Rosario, Puglisi Giovanni, Gulisano Massimo

机构信息

Dipartimento di Oncologia Sperimentale, Istituto Oncologico del Mediterraneo, Viagrande (CT), Italy.

出版信息

BMC Cancer. 2008 Jul 25;8:212. doi: 10.1186/1471-2407-8-212.

DOI:10.1186/1471-2407-8-212
PMID:18657273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2519087/
Abstract

BACKGROUND

PTX is one of the most widely used drug in oncology due to its high efficacy against solid tumors and several hematological cancers. PTX is administered in a formulation containing 1:1 Cremophor EL (polyethoxylated castor oil) and ethanol, often responsible for toxic effects. Its encapsulation in colloidal delivery systems would gain an improved targeting to cancer cells, reducing the dose and frequency of administration.

METHODS

In this paper PTX was loaded in PLGA NS. The activity of PTX-NS was assessed in vitro against thyroid, breast and bladder cancer cell lines in cultures. Cell growth was evaluated by MTS assay, intracellular NS uptake was performed using coumarin-6 labelled NS and the amount of intracellular PTX was measured by HPLC.

RESULTS

NS loaded with 3% PTX (w/w) had a mean size < 250 nm and a polydispersity index of 0.4 after freeze-drying with 0.5% HP-Cyd as cryoprotector. PTX encapsulation efficiency was 30% and NS showed a prolonged drug release in vitro. An increase of the cytotoxic effect of PTX-NS was observed with respect to free PTX in all cell lines tested.

CONCLUSION

These findings suggest that the greater biological effect of PTX-NS could be due to higher uptake of the drug inside the cells as shown by intracellular NS uptake and cell accumulation studies.

摘要

背景

由于紫杉醇(PTX)对实体瘤和几种血液系统癌症具有高效性,它是肿瘤学中使用最广泛的药物之一。PTX以含有1:1聚氧乙烯蓖麻油(Cremophor EL)和乙醇的制剂形式给药,这些成分常导致毒性作用。将其封装在胶体递送系统中可改善对癌细胞的靶向性,减少给药剂量和频率。

方法

本文将PTX负载于聚乳酸-羟基乙酸共聚物纳米粒(PLGA NS)中。在体外评估了PTX-NS对培养的甲状腺癌、乳腺癌和膀胱癌细胞系的活性。通过MTS法评估细胞生长,使用香豆素-6标记的纳米粒进行细胞内纳米粒摄取实验,并通过高效液相色谱法测量细胞内PTX的量。

结果

以0.5%羟丙基-β-环糊精(HP-Cyd)作为冷冻保护剂冻干后,负载3%(w/w)PTX的纳米粒平均粒径<250 nm,多分散指数为0.4。PTX的包封率为30%,纳米粒在体外显示出药物的缓释。在所有测试的细胞系中,观察到PTX-NS相对于游离PTX的细胞毒性作用增强。

结论

这些发现表明,PTX-NS更大的生物学效应可能归因于细胞内纳米粒摄取和细胞积累研究所示的药物在细胞内的更高摄取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/ab222b168ca6/1471-2407-8-212-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/b592a76a112e/1471-2407-8-212-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/bdff87ce0f5c/1471-2407-8-212-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/9d20e5d9b6e8/1471-2407-8-212-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/eabec73560a7/1471-2407-8-212-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/271a011c8c81/1471-2407-8-212-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/d05d5bd0f21e/1471-2407-8-212-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/ab222b168ca6/1471-2407-8-212-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/b592a76a112e/1471-2407-8-212-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/bdff87ce0f5c/1471-2407-8-212-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/9d20e5d9b6e8/1471-2407-8-212-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/eabec73560a7/1471-2407-8-212-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/271a011c8c81/1471-2407-8-212-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/d05d5bd0f21e/1471-2407-8-212-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/2519087/ab222b168ca6/1471-2407-8-212-7.jpg

相似文献

1
Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.聚乳酸-羟基乙酸共聚物纳米球中紫杉醇的负载量影响了药物的体外细胞蓄积和抗增殖活性。
BMC Cancer. 2008 Jul 25;8:212. doi: 10.1186/1471-2407-8-212.
2
Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.EpCAM抗体功能化的载紫杉醇PLGA纳米颗粒对视网膜母细胞瘤细胞的体外抗增殖作用增强。
Mol Vis. 2011;17:2724-37. Epub 2011 Oct 19.
3
Development of PLGA-based itraconazole injectable nanospheres for sustained release.聚乳酸-羟基乙酸共聚物载酮康唑注射纳米球的研制及其缓释特性
Int J Nanomedicine. 2013;8:4521-31. doi: 10.2147/IJN.S54040. Epub 2013 Nov 21.
4
Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.新型紫杉醇载 PLGA 纳米粒的研制:对前列腺癌细胞的抗增殖活性及其分子相互作用的研究。
Int J Pharm. 2013 Oct 1;454(2):712-9. doi: 10.1016/j.ijpharm.2013.05.018. Epub 2013 May 21.
5
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.载紫杉醇的聚乙二醇化聚乳酸-羟基乙酸共聚物纳米粒:体内外评价
J Control Release. 2009 Jan 5;133(1):11-7. doi: 10.1016/j.jconrel.2008.09.086. Epub 2008 Oct 9.
6
Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.开发青蒿琥酯与负载于聚(d,l-乳酸-共-乙醇酸)纳米颗粒中的紫杉醇的组合,用于全身给药以展现协同化疗反应。
Drug Dev Ind Pharm. 2017 Dec;43(12):1952-1962. doi: 10.1080/03639045.2017.1357729. Epub 2017 Aug 3.
7
Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.用于紫杉醇递送的热敏性及可生物降解的聚合物胶束
J Control Release. 2005 Mar 21;103(2):341-53. doi: 10.1016/j.jconrel.2004.12.009.
8
A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.一种新型的高非离子表面活性剂含量的 PLGA 纳米制剂提高了紫杉醇对肺癌的体外和体内活性。
Pharmacol Res. 2019 Mar;141:451-465. doi: 10.1016/j.phrs.2019.01.013. Epub 2019 Jan 8.
9
Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide--glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer.负载紫杉醇且靶向A10-3.2适配体的聚(丙交酯-乙交酯)纳米泡用于前列腺癌的超声成像与治疗
Int J Nanomedicine. 2017 Jul 26;12:5313-5330. doi: 10.2147/IJN.S136032. eCollection 2017.
10
Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.新型紫杉醇载 PLGA 微球的形态学研究用于有效的癌症治疗:体外与体内评价。
Drug Deliv. 2018 Nov;25(1):166-177. doi: 10.1080/10717544.2017.1422296.

引用本文的文献

1
Advancing triple-negative breast cancer treatment through peptide decorated solid lipid nanoparticles for paclitaxel delivery.通过肽修饰的固体脂质纳米粒递送紫杉醇推进三阴性乳腺癌治疗
Sci Rep. 2025 Feb 19;15(1):6043. doi: 10.1038/s41598-025-90107-y.
2
Antiproliferative Effect of Methanolic Extract of (Asteraceae) on Human Tumoral HeLa Cells Nanoencapsulated into PLGA-Nanoparticles.菊科植物甲醇提取物对纳米包裹于聚乳酸-羟基乙酸共聚物纳米粒中的人肿瘤性海拉细胞的抗增殖作用
Materials (Basel). 2025 Jan 27;18(3):580. doi: 10.3390/ma18030580.
3
Gold Half-Shell-Coated Paclitaxel-Loaded PLGA Nanoparticles for the Targeted Chemo-Photothermal Treatment of Cancer.

本文引用的文献

1
Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel.纳米白蛋白结合型紫杉醇:一种新型不含聚氧乙烯蓖麻油的紫杉醇制剂。
Nanomedicine (Lond). 2007 Aug;2(4):415-23. doi: 10.2217/17435889.2.4.415.
2
Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53).每周使用紫杉醇和卡铂同步放化疗治疗局部晚期头颈癌:布朗大学肿瘤学组II期研究(HN-53)的长期随访
Head Neck. 2008 Mar;30(3):289-96. doi: 10.1002/hed.20700.
3
In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel.
用于癌症靶向化疗-光热治疗的金半壳包覆载紫杉醇聚乳酸-羟基乙酸共聚物纳米粒
Micromachines (Basel). 2023 Jul 8;14(7):1390. doi: 10.3390/mi14071390.
4
Evaluation of paclitaxel-loaded polymeric nanoparticles in 3D tumor model: impact of tumor stroma on penetration and efficacy.载紫杉醇聚合物纳米粒在 3D 肿瘤模型中的评价:肿瘤基质对渗透和疗效的影响。
Drug Deliv Transl Res. 2023 May;13(5):1470-1483. doi: 10.1007/s13346-023-01310-1. Epub 2023 Feb 28.
5
Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer.聚(乳酸-乙醇酸)纳米粒改善紫杉醇对乳腺癌治疗效果的评估
Bioimpacts. 2022;12(6):515-531. doi: 10.34172/bi.2022.23433. Epub 2022 Jan 15.
6
Efficient Tumor Eradication at Ultralow Drug Concentration via Externally Controlled and Boosted Metallic Iron Magnetoplasmonic Nanocapsules.通过外部控制和增强的金属铁磁等离子体纳米胶囊实现超低药物浓度下的高效肿瘤清除。
ACS Nano. 2023 Feb 14;17(3):1946-1958. doi: 10.1021/acsnano.2c05733. Epub 2022 Dec 5.
7
Photoacoustic Imaging Quantifies Drug Release from Nanocarriers via Redox Chemistry of Dye-Labeled Cargo.光声成像是通过染料标记货物的氧化还原化学来量化纳米载体的药物释放。
Angew Chem Int Ed Engl. 2020 Mar 16;59(12):4678-4683. doi: 10.1002/anie.201914120. Epub 2020 Jan 24.
8
Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.新型纳米治疗方法在异种移植到裸鼠体内后可有效靶向人类卵巢癌干细胞。
Int J Mol Sci. 2017 Apr 12;18(4):813. doi: 10.3390/ijms18040813.
9
Aptamer-labeled PLGA nanoparticles for targeting cancer cells.用于靶向癌细胞的适体标记聚乳酸-羟基乙酸共聚物纳米颗粒。
Cancer Nanotechnol. 2012;3(1-6):1-12. doi: 10.1007/s12645-011-0024-6. Epub 2012 Jan 19.
10
Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy.中期因子作为上皮性卵巢癌顺铂/紫杉醇联合临床治疗的潜在诊断标志物。
Am J Cancer Res. 2015 Jan 15;5(2):629-38. eCollection 2015.
脂质纳米囊作为紫杉醇有前景的胶体载体的体内评价
Int J Pharm. 2007 Nov 1;344(1-2):143-9. doi: 10.1016/j.ijpharm.2007.06.014. Epub 2007 Jun 19.
4
Freeze-drying of nanoparticles: formulation, process and storage considerations.纳米颗粒的冷冻干燥:制剂、工艺及储存考量
Adv Drug Deliv Rev. 2006 Dec 30;58(15):1688-713. doi: 10.1016/j.addr.2006.09.017. Epub 2006 Oct 6.
5
Pharmacogenetics of paclitaxel metabolism.紫杉醇代谢的药物遗传学
Crit Rev Oncol Hematol. 2007 Mar;61(3):222-9. doi: 10.1016/j.critrevonc.2006.09.006. Epub 2006 Nov 7.
6
Lyoprotected nanosphere formulations for paclitaxel controlled delivery.用于紫杉醇控释的冻干保护纳米球制剂
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3118-25. doi: 10.1166/jnn.2006.452.
7
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery.癌症治疗中的纳米技术:用于药物递送的生物共轭纳米颗粒
Mol Cancer Ther. 2006 Aug;5(8):1909-17. doi: 10.1158/1535-7163.MCT-06-0141.
8
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.纳米颗粒包裹的紫杉醇对P-糖蛋白介导的药物外排的敏感性。
Int J Pharm. 2006 Aug 31;320(1-2):150-6. doi: 10.1016/j.ijpharm.2006.03.045. Epub 2006 Apr 7.
9
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.c-IAP1、survivin和Smac的表达改变促成甲状腺癌细胞的化疗耐药性。
Cancer Res. 2006 Apr 15;66(8):4263-72. doi: 10.1158/0008-5472.CAN-05-3248.
10
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.间变性甲状腺癌:生物学、发病机制、预后因素及治疗方法
Ann Surg Oncol. 2006 Apr;13(4):453-64. doi: 10.1245/ASO.2006.05.042. Epub 2006 Feb 15.